9.4crit

CVE-2018-14786

Becton, Dickinson and Company (BD) Alaris Plus medical syringe pumps (models Alaris GS, Alaris GH, Alaris CC, and Alaris TIVA) versions 2.3…

Published 8 y ago · modified 4 mo ago · JSON

CVSS
9.4
v3.0 · NVD
CISA KEV
No
not known exploited
EPSS
2.9%
percentile 87%
Public exploits
0
none known

Summary

Becton, Dickinson and Company (BD) Alaris Plus medical syringe pumps (models Alaris GS, Alaris GH, Alaris CC, and Alaris TIVA) versions 2.3.6 and prior are affected by an improper authentication vulnerability where the software does not perform authentication for functionality that requires a provable user identity, where it may allow a remote attacker to gain unauthorized access to various Alaris Syringe pumps and impact the intended operation of the pump when it is connected to a terminal server via the serial port.

Exploit prediction (EPSS)

2.94% probability of exploitation in the next 30 days, higher than 87% of all scored CVEs.

CVSS scores

Assigned byVersionScoreVector
NVD3.09.4CVSS:3.0/AV:N/AC:L/PR:N/UI:N/S:U/C:L/I:H/A:H
NVD2.07.5AV:N/AC:L/Au:N/C:P/I:P/A:P

Affected products

  • Becton, Dickinson and Company Alaris GS, Alaris GH, Alaris CC, and Alaris TIVA

Classification

Weakness

References

  • securityfocus.com /bid/105147 · vdb-entry, x_refsource_BID, x_transferred
  • bd.com /en-us/support/product-security-and-privacy/product-security-bulletin-for-various-alaris-p · x_refsource_CONFIRM, x_transferred
  • ics-cert.us-cert.gov /advisories/ICSMA-18-235-01 · x_refsource_MISC, x_transferred

Sources

vulnwire keeps one entry per vulnerability: the CVE id wins, then GHSA; records that alias each other are merged. Machine-readable: JSON.